Are ruxolitinib tablets a hormonal drug? How are its effects and side effects different from those of hormonal drugs?

Ruxolitinib (JAKAVI) is a Janus kinase inhibitor. Unlike hormonal drugs, it is not a hormonal drug. JAKAVIBy inhibiting the Janus kinase (JAK) signaling pathway, it prevents the transmission of cell signals, thereby reducing the proliferation and inflammatory response of abnormal cells. It is mainly used to treat diseases such as myelofibrosis and primary myeloproliferative disorders. Unlike hormonal drugs, JAKAVI's mechanism of action targets the signaling pathways within cells rather than directly affecting hormone levels.

JAKAVIBy inhibiting Januskinase1 and Janus< /span>kinases2 (JAK1 and JAK2 ) function. JAK1 and JAK2 are important intracellular enzymes, involved in the regulation of a variety of cell growth, differentiation and immune responses. By inhibiting these kinases, JAKAVI regulates and reduces abnormal blood cell production and excessive immune responses in the body. Therefore, JAKAVI's mechanism of action is very different from traditional hormone drugs, which mainly produce effects by changing the levels of hormones in the body.

Hormonal drugs, such as steroids, mainly produce effects by regulating hormone levels in the body, especially by changing the secretion of steroids such as cortisol in the body to control inflammation, immune response and cell metabolism. They reduce inflammation or immune-mediated diseases by affecting activation of the immune system. The effect of JAKAVI is to directly inhibit the JAK signaling pathway, affecting immune response and blood cell production. Therefore, it does not involve changes in hormone levels.

Compared with hormonal drugs, JAKAVI has different side effects. Common side effects include anemia, thrombocytopenia, leukopenia, etc. These side effects are usually related to JAKAVI's effect on bone marrow. In addition, patients may also suffer from liver function damage, infection, gastrointestinal discomfort and other problems. In contrast, the side effects of hormonal drugs focus more on problems caused by long-term use such as weight gain, edema, hyperglycemia, and osteoporosis.

JAKAVI is mainly used to treat diseases caused by JAK2 mutations such as myelofibrosis, and can effectively relieve symptoms and improve quality of life. Hormone drugs are widely used in a variety of immune diseases and inflammatory diseases, usually for short-term relief of symptoms. When using JAKAVI, the patient's treatment goal is to improve hematological indicators by regulating the immune system and cell production, while the use of hormonal drugs focuses more on relieving acute inflammatory reactions and controlling disease symptoms.

Reference materials:https://www.jakavi.com/